Scimplify's raise sits on a clear backdrop: manufacturers want sources for critical materials outside China. On October 14, 2026, TechCrunch reported that the Bengaluru-based startup had closed a $25 million all-equity strategic round led by Hitachi Ventures, with customers Henkel and Teknor Apex joining as new investors and existing backers including Accel India participating. Total equity funding reaches $80 million; a person familiar with the deal put the post-money valuation near $250 million, a figure the company itself declined to confirm.
What Scinode does: routes, factories, quality
Founded in 2023, Scimplify does not build heavy plants of its own. It develops chemical manufacturing processes at its labs in Bengaluru and Hyderabad, then transfers them to partner factories for commercial production across a network of more than 500 facilities. Its proprietary platform, Scinode, coordinates the work: identifying suitable production routes and plants for each order while tracking quality and regulatory requirements, with specialized AI agents split across research, manufacturing and quality control. Co-founder Sachin Santhosh said some projects have gone from customer requirements to finished material in two months, against a typical 12 to 18 months — a company claim, with timelines varying by project.
Revenue mix has tilted to electronics, energy and defence
The numbers show where demand comes from: an annualized revenue run rate of about $200 million, tripled in a year, with a $400 million target for next year; US run-rate revenue near $60 million, up sixfold, at roughly 30% of the business; customers outside India now contribute over half of revenue, versus under 5% some 18 months ago. Energy, electronics and defence together account for 45% to 50% of revenue, up from under 15% a year ago. The company serves more than 1,000 customers, has delivered to over 40 countries, employs about 340 people including roughly 70 scientists, and says it has been EBITDA-positive for the past two months.
Where the money goes, and what stays hard
About $7.5 million of the new funding is earmarked for US expansion and its manufacturing network there, with another $2 million for Scinode development. Roughly 90% of manufacturing still happens in India, with plans to extend the network to the US and Japan over the next year; on products, it is working on tungsten derivatives recovered from scrap and on rare-earth materials — categories whose supply is heavily concentrated in China. The sober point: specialty-chemical substitution is not a software business. Every new route must clear process development, facility qualification and strict quality standards; AI agents compress the search, matching and coordination time, but validation and scale-up risk do not disappear. The real test is whether quality consistency across 500-plus partner factories can keep pace with revenue tripling year on year.
